Moni Miyashita elected to Halozyme Board of Directors

HALOZYME THERAPEUTICS, INC.

Elected March 11, 2022, term ends at 2023 annual meeting.
No initial committee assignment on the Board.
Receives standard non-employee director compensation (cash retainers and restricted stock).
No arrangements, understandings, or related person transactions with the Company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Moni Miyashita

Director

HALO · HALOZYME THERAPEUTICS, INC.

Effective: 2022-03-11
Filed: March 15, 2022, 7:59 PM ET

On March 11, 2022, Moni Miyashita was elected to the Board of Directors of Halozyme Therapeutics, Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Moni Miyashita was elected as Director at HALOZYME THERAPEUTICS, INC..

Action: elected
Role: Director

Exact text from the filing

On March 11, 2022, Moni Miyashita was elected to the Board of Directors of Halozyme Therapeutics, Inc.

View on SEC.gov

HALOZYME THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001159036-22-000019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.